Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MJ Cabanas-Poy"'
Autor:
BR Vila-Indurain, MJ Cabanas-Poy, B Garcia-Palop, MT Garriga-Baraut, C Canete-Ramirez, C Blasco-Valero, S Clemente-Bautista, I Jimenez-Lozano, M Larrosa García
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Omalizumab-assisted oral-induced tolerance (oaOTI) has been proved to reduce the number of adverse events and shorten the time needed to reach tolerance compared to conventional OTI in patients with high-risk food allergy (hrFA). However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bafcc56f06c2a52f19197f082758f010
https://doi.org/10.1136/ejhpharm-2019-eahpconf.285
https://doi.org/10.1136/ejhpharm-2019-eahpconf.285
Autor:
B Garcia-Palop B, A Morgenstern Isaak, C Cuso Cuquerella, I Jimenez Lozano, A Fernandez-Polo A, MJ Cabanas Poy, C Rodrigo Gonzalo de Liria, MQ Gorgas Torner
Publikováno v:
National Poster Prize Winners.
Background Parenteral medication administration by continuous infusion has become a common practice in end-of-life home care settings because portable infusion pumps are well tolerated and maintain more nearly constant drug plasma levels. Purpose To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98de94b37e921464f7cb070251c8177a
https://doi.org/10.1136/ejhpharm-2019-eahpconf.637
https://doi.org/10.1136/ejhpharm-2019-eahpconf.637